,0
symbol,XCUR
price,1.72
beta,0.0
volAvg,177081
mktCap,150033200
lastDiv,0.0
range,0.957-3.84
changes,-0.04
companyName,Exicure Inc
currency,USD
cik,0001698530
isin,US30205M1018
cusip,30205M101
exchange,NasdaqGS
exchangeShortName,NASDAQ
industry,Biotechnology
website,http://www.exicuretx.com/
description,"Exicure, Inc. is a clinical-stage biotechnology company, which engages in the discovery, research, and development of treatments based on spherical nucleic acid technology (SNA). The company is headquartered in Skokie, Illinois and currently employs 33 full-time employees. The firm is focused on developing gene regulatory and immuno-oncology therapeutics-based on its proprietary spherical nucleic acid (SNA) technology. SNAs are nanoscale constructs consisting of densely packed synthetic nucleic acid sequences that are radially arranged in three dimensions. The Companyâ€™s intellectual property portfolio includes 125 pending patent applications and 45 allowed or issued patents. These filings impact numerous jurisdictions worldwide, and they cover a range of inventions, including fundamental nanoparticle manufacturing breakthroughs and numerous application-specific improvements."
ceo,Dr. David Giljohann
sector,Healthcare
country,US
fullTimeEmployees,43
phone,18476731700
address,8045 Lamon Ave Ste 410
city,Skokie
state,ILLINOIS
zip,60077
dcfDiff,
dcf,2.53027
image,https://financialmodelingprep.com/image-stock/XCUR.png
ipoDate,2018-05-09
defaultImage,False
